Study of High-Dose Resveratrol in Patients With Stable Ischemic Heart Disease

by | Apr 7, 2025 | Clinical Trials | 0 comments

​ Conditions: Ischaemic Heart Desease

Interventions: Dietary Supplement: High-dose resveratrol 500 mg/day; Other: Placebo

Sponsors: S.LAB (SOLOWAYS); Center for New Medical Technologies, Novosibirsk, Russia

Completed Conditions: Ischaemic Heart Desease
Interventions: Dietary Supplement: High-dose resveratrol 500 mg/day; Other: Placebo
Sponsors: S.LAB (SOLOWAYS); Center for New Medical Technologies, Novosibirsk, Russia
Completed 

Submit a Comment

Your email address will not be published. Required fields are marked *